Herbal supplements recalled; may contain drugs not listed on label – WFTV

If the ingredients are included in a product, it cannot be marketed as a dietary supplement, the FDA said.

The agency also stated that the supplement was not approved as a new drug “whose safety and efficacy have not yet been established and which could therefore be subject to a recall.”

The FDA stated that taking these supplements carries the risk of an intentional overdose of acetaminophen, which could lead to liver damage.

Diclofenac is a nonsteroidal anti-inflammatory drug, or NSAID. Taking NSAIDs may increase the risk of cardiovascular disease and gastrointestinal damage and may interact with other medications.

Phenylbutazone is a discontinued NSAID that can cause bone marrow damage. It is not approved for use in humans.

The recalled Infla-650 herbal supplement capsules were sold with the lot number IN-032 and an expiration date of November 2027. They have a silver stand-up pouch that contains 60 capsules. They were shipped to retailers nationwide and through nutraherbusa.com and nutra650.com from March 4 to June 24.

Anyone in possession of the supplements is advised not to take them and to return them to where they purchased them, the FDA said.